TRPV1 and neoplasm: In keeping with this hypothesis, olvanil, a non-pungent vanilloid agonist that activates TRPV1 more slowly than capsaicin does [81,82], was shown to suppress metastasis of breast carcinoma without altering the rate of primary tumor growth [83].